9AZK
Macrocyclic inhibitors targeting the prime site of the fibrinolytic serine protease plasmin
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2022-04-06 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9537 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 74.851, 128.875, 79.081 |
Unit cell angles | 90.00, 108.06, 90.00 |
Refinement procedure
Resolution | 47.760 - 2.100 |
R-factor | 0.2379 |
Rwork | 0.237 |
R-free | 0.25490 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5ugd |
RMSD bond length | 0.013 |
RMSD bond angle | 1.650 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.2_4158) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.760 | 2.210 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.221 | 1.599 |
Rmeas | 0.240 | 1.742 |
Rpim | 0.093 | 0.682 |
Number of reflections | 82977 | 8220 |
<I/σ(I)> | 7.4 | 1.5 |
Completeness [%] | 99.8 | 99.77 |
Redundancy | 6.5 | |
CC(1/2) | 0.990 | 0.429 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.1 M Tris-HCl, 0.2 M ammonium phosphate monobasic |